Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
World Journal of Gastroenterology
|
October 13, 2006
Heavy smoking and liver
Abdel-Rahman El-Zayadi
World Journal of Gastroenterology
|
October 28, 2009
Hepatitis C comorbidities affecting the course and response to therapy
Abdel-Rahman El-Zayadi
World Journal of Gastroenterology
|
July 19, 2008
Hepatic steatosis: a benign disease or a silent killer
Abdel-Rahman El-Zayadi
World Journal of Gastroenterology
|
February 2, 2012
Hepatitis C virus induced insulin resistance impairs response to anti viral therapy
Abdel-Rahman El-Zayadi, Mahmoud Anis
Mediators of Inflammation
|
October 19, 2011
Apelin serum level in Egyptian patients with chronic hepatitis C
Hala O El-Mesallamy, Nadia M Hamdy, Hanan H Rizk, et al.
Hepatology International
|
September 10, 2010
Effect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patients
Abdel-Rahman El-Zayadi, Hanaa M Badran, Sherine Shawky, et al.
The American Journal of Gastroenterology
|
March 19, 2009
Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy
Abdel-Rahman El-Zayadi, Hanaa Mostafa Badran, Ahmed Saied, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 7, 2005
Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy
Abdel-Rahman El-Zayadi, Mohy Attia, Hanaa M Badran, et al.
World Journal of Gastroenterology
|
August 30, 2005
Hepatocellular carcinoma in Egypt: a single center study over a decade
Abdel-Rahman el-Zayadi, Hanaa M Badran, Eman M F Barakat, et al.
The American Journal of Gastroenterology
|
November 11, 2005
Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study
Abdel-Rahman El-Zayadi, Mohy Attia, Eman M F Barakat, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
World Journal of Gastroenterology
|
October 13, 2006
Heavy smoking and liver
Abdel-Rahman El-Zayadi
World Journal of Gastroenterology
|
October 28, 2009
Hepatitis C comorbidities affecting the course and response to therapy
Abdel-Rahman El-Zayadi
World Journal of Gastroenterology
|
July 19, 2008
Hepatic steatosis: a benign disease or a silent killer
Abdel-Rahman El-Zayadi
World Journal of Gastroenterology
|
February 2, 2012
Hepatitis C virus induced insulin resistance impairs response to anti viral therapy
Abdel-Rahman El-Zayadi, Mahmoud Anis
Mediators of Inflammation
|
October 19, 2011
Apelin serum level in Egyptian patients with chronic hepatitis C
Hala O El-Mesallamy, Nadia M Hamdy, Hanan H Rizk, et al.
Hepatology International
|
September 10, 2010
Effect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patients
Abdel-Rahman El-Zayadi, Hanaa M Badran, Sherine Shawky, et al.
The American Journal of Gastroenterology
|
March 19, 2009
Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy
Abdel-Rahman El-Zayadi, Hanaa Mostafa Badran, Ahmed Saied, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 7, 2005
Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy
Abdel-Rahman El-Zayadi, Mohy Attia, Hanaa M Badran, et al.
World Journal of Gastroenterology
|
August 30, 2005
Hepatocellular carcinoma in Egypt: a single center study over a decade
Abdel-Rahman el-Zayadi, Hanaa M Badran, Eman M F Barakat, et al.
The American Journal of Gastroenterology
|
November 11, 2005
Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study
Abdel-Rahman El-Zayadi, Mohy Attia, Eman M F Barakat, et al.
Page
of 2